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 phenytoin.  Teratological studies in this strain are 
ongoing.  Phenytoin concentrations in fetal brain 
determined by HPLC were about 60% higher than 
those in fetal liver, which were similar to those in 
both maternal liver and brain.  These results suggest 
than the acatalasemic mouse strain may be relatively 
resistant to phenytoin-enhanced ROS formation and 
teratogenicity, requiring further optimization of the 
treatment regimen to evaluate the embryoprotective 
role of endogenous catalase.  The lower constitutive 
and phenytoin-enhanced DNA oxidation in catalase 
overexpressing embryos suggests a protective role 
for endogenous catalase, although the teratological 
relevance remains to be determined.  The increased 
concentration of phenytoin in fetal brain compared 
to fetal liver and maternal tissues may explain the 
high frequency of neurodevelopmental deficits 
compared to other anomalies caused by this drug, 
and raises interesting questions as to the mechanisms 
underlying this selectivity.   
(Support: CIHR.  Abstract reproduced from Birth 
Defects Res. Part A [in press], 2009.) 
 
50. Hepatic Expression of ABC Drug 
Transporters in Rodent Models of 
Inflammation During Pregnancy 
 
Vanja Petrovic and Micheline Piquette-Miller.  
Leslie Dan Faculty of Pharmacy, University of 
Toronto, Toronto, ON, Canada. 
 
Purpose: While various rodent models of 
inflammation and infection have been established, 
few have focused on using pregnant rats.  Pregnancy 
induces a number of physiological changes which 
may affect the response of these rats to an infectant.  
Our objective was to compare three different 
inflammation models using pregnant rats in order to 
determine the best one for use in future 
pharmacokinetic studies.  We examined the models 
in terms of their effect on the expression of several 
key hepatic drug transporters and the metabolizing 
enzyme Cyp3a, as these genes are known to be 
affected by the inflammatory response and also have 
many clinically relevant substrates. 
Methods: Pregnant SD rats (G17-18, n=3-6/group) 
were administered single i.p. doses of the following 
infectants: bacterial endotoxin (LPS, 0.1 - 1.0 
mg/kg), polyinosinic:polycytidylic acid (poly I:C, 
0.75 - 5.0 mg/kg), or interleukin-6 (IL-6, 1g/rat).  
Control pregnant rats received saline.  Animals were 
sacrificed 6-24 hrs later and hepatic mRNA levels of 
P-glycoprotein (Mdr1a and Mdr1b), Mrp2, Bcrp, 
Oatp2, and Cyp3A were measured via real-time 
PCR. 
Results: At the given doses, LPS and poly I:C 
models were the only to have a significant effect on 
hepatic drug transporter and Cyp3a expression levels 
as compared to controls.  No significant differences 
were observed with the IL-6 model at the given 
dose. Expression profiles of mRNA levels were 
similar between the LPS and poly I:C models, with 
significant downregulation (p<0.05) of all examined 
genes except for Mdr1b, which was significantly 
induced.  However, LPS was more toxic for 
pregnant rats than poly I:C was. 
Conclusion: Both, LPS and poly I:C-induced 
inflammation in pregnant rats are effective for 
studying the impact of inflammation on hepatic drug 
transporters and drug disposition of their substrates.  
From our observations, poly I:C was safer for use in 
pregnant rats as it resulted in less mortalities.  IL-6 
dosing would have to be optimized in order to 
provide an effective model, but this may be costly as 
cytokines are an expensive medium.  
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Purpose: The skin surface biopsy by tape stripping 
allows successive sampling of the stratum corneum 
(SC) at increasing depths.  However, SC thickness 
varies between subjects and sites and the amount of 
SC material removed varies between strips.  This 
work shows a method by which the relative SC 
depth and amount removed with each strip can be 
determined. 
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 Methods: A site on the inner volar forearms of nine 
normal human volunteers was stripped 20 times with 
14 mm CuDerm discs.  After each strip, 
transepidermal water loss (TEWL) was measured at 
the site with a Tewameter (Courage-Khazaka).  The 
absorbance of each strip was read at 850 nm 
(SquameScan 850).  These procedures were repeated 
using excised human skin from a single female 
donor (11 replicates).  Recognizing that Fick’s 1st 
Law describes water diffusion through the SC 
membrane, a linear relationship exists between the 
inverse of TEWL and the thickness of the membrane 
after each strip.  The thickness of the unstripped SC 
is given by the x-axis intercept of such a plot.  As 
absorbance (A) is proportional to the thickness of the 
absorbing material (Beer-Lambert Law), the 
cumulative absorbance (Acum) of the material on the 
strips can be substituted for thickness to obtain a 
similar relationship.  This allows us to obtain a depth 
at each tape strip relative to the total depth.  It also 
allows comparison between individual subjects. 
Results: The predicted theoretical relationship 
between (TEWL)-1 and Acum was verified 
experimentally for the human subjects (see figure).  
The mean percentage of SC removed after 20 strips 
was 49.2% (%CV=21.6).  There was significant 
variability in the SC thickness removed by the 20 
strips (represented by Acum values; mean=62.5, 
%CV=26.2).  The same linear relationship was also 
verified for excised skin (R2=0.9916).  The 
percentage of SC removed by 20 strips (mean=82.6, 
%CV 3.6%) was greater than seen for in vivo skin.  
As well, a greater absolute amount of SC was 
removed from the excised skin (mean Acum = 96.72, 
compared to 62.5 for in vivo skin). 
Conclusions: We demonstrated a simple method for 
determining relative depth in SC after tape stripping.  
While comparable methods were previously applied 
to in vivo skin, we showed for the first time that 
theoretical predictions also hold true in vitro.  Inter-
individual differences may explain the differences 
between in vivo skin and the single sample of 
excised skin, or they may reflect different rates of 
diffusion in non-living tissue. 
Reference: Herkenne, C. et al (2008) In vivo 
methods for the assessment of topical drug 
bioavailability Pharm Res 25(1):87-103. 
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Purpose: To evaluate a Cree botanical, AD09, used 
by the Cree of Eeyou Istchee to treat symptoms of 
type II diabetes (T2D), for its role in altering gene 
transcript changes in human Caco-2 intestinal cells. 
Also, to undertake a quantitative comparison of the 
phytochemical profiles of ethanol (EtOH) and 
traditional water (DW) extracts to determine the 
relevance of using an EtOH extract in laboratory 
studies. 
Methods: Human Caco-2 intestinal cells were 
exposed to AD09 at a concentration of 100 g/mL 
for a period of 4 and 24 hrs, the RNA was extracted, 
and microarray experiments were performed using 
human 19K cDNA arrays to establish gene changes 
with the extract versus 0.1 % DMSO control.  
Furthermore, cells were exposed to compound M, a 
major component of AD09 for 4 hours, at a 
concentration of 8.8 μg/mL, and microarray 
experiments performed.  Both extracts were 
analyzed by HPLC coupled with diode array 
detector and evaporative light scattering detector. 
Results: Microarray experiments for AD09 and 
compound M for 4 hrs revealed no statistically 
significant gene transcript changes.  However, the 
24-hr exposure to AD09 yielded 304 downregulated 
mRNAs (p<0.05) with a fold-change greater than 1.5 
with significant downregulation of key transcription 
factors and members of different signaling 
pathways.  A phytochemical evaluation yielded 
many similarities between the extracts in the 
different markers examined.  Only slight differences 
were observed in the polar and non-polar regions of 
the chromatograms. 
Conclusions:  AD09 did not cause transcript 
changes of the cytochrome P450s which are usually 
altered in the intestinal model of Caco-2 cells upon 
exposure to a xenobiotic, signifying that the 
botanical may be quite safe to use especially with 
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